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Abstract
Background: The diagnosis of chronic fatigue syndrome (CFS) in research studies requires the
exclusion of subjects with medical and psychiatric conditions that could confound the analysis and
interpretation of results. This study compares illness parameters between individuals with CFS who
have and those who do not have exclusionary conditions.
Methods:  We used a population-based telephone survey of randomly selected individuals,
followed by a clinical evaluation in the study metropolitan, urban, and rural counties of Georgia,
USA. The medical and psychiatric histories of the subjects were examined and they underwent
physical and psychiatric examinations and laboratory screening. We also employed the
multidimensional fatigue inventory (MFI), the medical outcomes survey short form-36 (SF-36) and
the US Centres for Disease Control and Prevention symptom inventory (SI).
Results: Twenty-nine percent (1,609) of the 5623 subjects who completed the detailed telephone
interview reported exclusionary diagnoses and we diagnosed an exclusionary condition in 36% of
781 clinically evaluated subjects. Both medical and psychiatric exclusionary conditions were more
common in women, blacks and participants from rural areas. Subjects with and without exclusions
had similar levels of fatigue and impairment as measured by the MFI and SF-36; those with CFS-like
illness (not meeting the formal CFS definition) were more likely to have an exclusionary diagnosis.
After adjusting for demographics, body mass index, fatigue subscales, SF-36 subscales and CFS
symptoms, CFS-like illness did not remain significantly associated with having an exclusionary
diagnosis.
Conclusion: Medical and psychiatric illnesses associated with fatigue are common among the
unwell. Those who fulfill CFS-like criteria need to be evaluated for potentially treatable conditions.
Those with exclusionary conditions are equally impaired as those without exclusions.
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Background
The diagnosis of chronic fatigue syndrome (CFS) for
research and clinical purposes is based on a clinical defi-
nition: persistent or relapsing fatigue of at least 6-months'
duration, that is not alleviated by rest and that causes a
substantial reduction in activities; a fatigue that cannot be
explained by medical or psychiatric conditions and must
be accompanied by at least four of the eight case defining
symptoms (unusual post exertional malaise, impaired
memory or concentration, unrefreshing sleep, headaches,
muscle pain, joint pain, sore throat and tender cervical
nodes) [1].
Since CFS definitions were originally formulated for
research purposes, the exclusion of active medical and
psychiatric illnesses or diseases associated with fatigue
was considered necessary for two reasons [1-5]. First,
some of those suffering such symptoms have an explana-
tion for their fatigue; and, secondly, mislabelling a condi-
tion that would respond to specific therapy (i.e., anaemia
or hypothyroidism) as CFS would not be appropriate. In
addition, those who had psychotic psychiatric illnesses
might not be able to realistically report their symptoms
and levels of function. Thus, certain diseases such as
hypothyroidism and diabetes mellitus are considered
exclusionary until adequately treated [4]. Other diseases
with core symptoms that are also seen in CFS - for exam-
ple, a major depressive disorder with melancholic features
(MDDM) or chronic hepatitis C - were considered perma-
nent exclusions because of their persistent or recurrent
course.
In addition to its use in research, the definition is widely
used for clinical purposes. The clinical application has
been hampered because it gives practitioners little guid-
ance on how to determine when a patient is sufficiently
impaired or symptomatic to warrant the diagnosis and
when to include patients with adequately treated 'exclu-
sionary' diseases who may continue to have symptoms
and consequences compatible with CFS. The first issue
was partly addressed by the application of empiric meth-
ods to the diagnostic process [6]. However, the problem
of how to handle exclusionary diseases remained unan-
swered. For example, patients with hypothyroidism or
systemic lupus erythematosus that is 'under control' or
inactive, based on physical examinations and laboratory
evaluations, may still fulfill the criteria for CFS. Clinically,
they are frequently managed as CFS patients, raising the
question of whether those who would meet the research
criteria for CFS, except for the single fact that they have an
exclusionary condition, are similar to those who fully
meet the CFS case definition criteria of fatigue severity,
impairment and specific symptoms and, by inference, of
the underlying pathophysiology of fatigue. It is also recog-
nized that, while the illnesses are considered exclusionary
because of their frequent association with fatigue, many
with those diagnosed do not have fatigue.
The purpose of this analysis is to describe the prevalence
of exclusionary diagnoses identified in a population-
based surveillance study of fatigue illnesses and to com-
pare those with and without such conditions in terms of:
(1) demographics; (2) specific exclusionary categories; (3)
the presence of CFS case-definition criteria; and (4) levels
and characteristics of fatigue and impairment. The fre-
quency with which potentially treatable conditions were
identified in subjects otherwise meeting research criteria
for CFS emphasizes the need for clinicians treating
patients presenting with unexplained fatigue to consider
these illnesses in the differential diagnosis.
Methods
This study was approved by the US Centers for Disease
Control and Prevention (CDC) Institutional Review
Board, as required by Department of Health and Human
Services regulations. All participants were volunteers who
gave their informed consent. The study was conducted in
English. Non-English speaking respondents were
excluded.
Study design
The study design was described in detail by Reeves et al.
[7]. Subject participation required contact with a screen-
ing interviewer, followed by a detailed telephone inter-
view and a clinic visit. Between September 2004 and July
2005 Georgia residents between the ages of 18 and 59
were identified for participation in a telephone screening
survey conducted in the metropolitan, urban and rural
areas of Georgia [8,9]. A household informant (≥ 18
years) identified as unwell any household members who
had had at least one of the four most common CFS defin-
ing symptoms (fatigue, cognitive impairment, un-refresh-
ing sleep, muscular or joint pain) for ≥ 1 month and as
well those who had experienced none of these problems
for ≥ 1 month.
All those identified as unwell with fatigue, as well as ran-
domly selected persons identified as well and as unwell
without fatigue, were asked to complete a detailed com-
puter assisted telephone interview (CATI). On the basis of
the telephone interview respondents were classified as:
(1) having a medical or psychiatric condition considered
exclusionary; (2) having a CFS-like illness characterized
by severe fatigue lasting for 6 months or longer that was
not alleviated by rest, that caused a substantial reduction
in occupational, educational, social or personal activities
and that was accompanied by at least four of the CFS case
defining symptoms (tentatively CFS pending clinical eval-
uation); (3) having prolonged (≥ 1 month) or chronic (≥
6 months) unwellness with or without fatigue, but notBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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meeting criteria for CFS; or (4) being well. All respondents
classified as CFS-like (n = 469), those classified as chroni-
cally unwell (n = 505), and the randomly selected well (n
= 641) matched to the CFS-like classification on age, sex
and geographic area were invited to a 1-day clinic where
they were given a physical examination, a psychiatric
interview, laboratory screening and completed self-
administered questionnaires. Final classification catego-
ries include: (1) CFS; (2) insufficient fatigue (ISF; subjects
who have been ill for > 6 months, but do not fulfill all cri-
teria for CFS); (3) non-fatigued (NF); and (4) subjects
who appeared in each category but for an exclusionary
diagnosis.
Data collection
Demographic data (age, sex, race, geographic strata) and
past medical and psychiatric history data were obtained
via telephone interviews and confirmed at clinic by self-
administered questionnaires. Height and weight were
measured at the clinic; body mass index (BMI) was calcu-
lated as the ratio of weight in kilograms to height in
metres squared. To complete the screening for existing,
but unidentified, medical and psychiatric conditions, par-
ticipants reviewed current medications and medical his-
tory with clinic personnel and had a complete physical
examination with laboratory tests recommended for the
evaluation of possible CFS. In addition, a psychiatric
interview was conducted using the structured clinical
interview for disorders described in the forth edition of
the Diagnostic and Statistical Manual for Mental Disorders
(SCID DSM-IV) [10]. A review committee of CDC and
Emory University physicians and psychologists reviewed
all the data collected at the clinic visits to determine the
presence of medical and psychiatric conditions consid-
ered exclusionary for CFS.
We used the multidimensional fatigue inventory (MFI)
[11] to assess the fatigue status. Functional impairment
was assessed by the medical outcomes survey short form-
36 (SF-36) [12]. The SF-36 also yields two summary scores
that reflect the two-dimensional factor structure underly-
ing the eight subscales: a physical component summary
(PCS) score and a mental component summary (MCS)
score [13]. Nichol's health utility index (HU12) was gen-
erated from eight subscales of SF-36 [14]. We used the
CDC symptom inventory (SI) [15] to evaluate occurrence,
frequency and severity of the eight CFS-defining and 10
accompanying symptoms.
Statistical analyses
General linear models were performed in order to exam-
ine the bivariate associations between health outcome
measures (fatigue, functional impairments and symp-
toms) and the following covariates: (1) diagnostic sub-
groups (CFS-like, unwell or well); (2) exclusion status
(included or excluded); (3) demographics such as sex,
age, race or geographic stratum; (4) BMI. Tukey-Kramer
tests were employed to test significance of ad hoc compar-
isons. We used logistic regression to generate odds ratios
(OR) as measures of the association between the inclu-
sion/exclusion status and the demographic factors and
qualitative health status. A multivariate logistic regression
model was used to examine the likelihood of a subject
being excluded with the adjustment of all other covariates
in the model. All tests of significance were two-sided with
the alpha level set at 0.05. The analyses were performed
using SAS version 9.1 (SAS Institute, Inc., Cary, NC, USA).
Results
Demographic characteristics
The study sample of 5,623 subjects at a CATI evaluation
(the detailed interview) were primarily female (64%),
white (65%), living in rural or urban areas (80%) with a
mean age of 41.6 years (data statistics not shown). Similar
distributions were present in the 781 subjects seen in the
clinic whose mean age was 43.5 years (see Table 1, Part A)
- the majority were female (76%), white (71%) and living
in rural or urban areas (83%).
Exclusionary conditions
Based on the responses of those completing the detailed
telephone interview: 907 met criteria of the 1994 CFS case
definition [1] and, prior to a clinical examination, we clas-
sified them as CFS-like; 3203 reported prolonged (≥ 1
month) or chronic (≥ 6 months) unwellness, with or
without fatigue, but not meeting criteria for CFS; and
1513 were well. In all, 1609 (28.6%) of those interviewed
reported a medical or psychiatric condition considered
exclusionary for CFS (Table 2). Four hundred and forty-
one (48%) of those classified as CFS-like reported such
conditions, as did 982 (37%) of the unwell and 186 of the
well (9%). Most (1341; 83%) of the excluded individuals
identified by the detailed interview had exclusionary med-
ical reasons for their exclusion (Table 3). About 60%
(814) of those excluded at this stage were reported to be:
morbidly obese (BMI ≥ 40); suffering narcolepsy or sleep
apnea; had been pregnant within the preceding year; had
HIV/AIDS; or had undergone an organ transplantation.
These exclusions rendered the individual ineligible for
clinical evaluation and they were, therefore, not evaluated
further.
As shown in Table 1, the CFS-like and unwell subjects
seen at clinic were more likely to have exclusionary diag-
noses than the well subjects, as were black individuals,
those from rural and urban settings and those with a
higher BMI (unadjusted ORs). However, after controlling
for all other factors in Table 1, only being black and resid-
ing in a rural or urban region remained significant
(adjusted ORs). As shown in Table 1 (Part B), having anBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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exclusionary condition was associated with worse fatigue,
worse impairment and more frequent and severe symp-
toms as measured by all subscales of the MFI, SF-36 and
SI, respectively (P < 0.0001; unadjusted OR). However,
when adjusted for all other variables in the table, only a
lower (worse) vitality score (the score representing fatigue
and energy) of the SF-36 was associated with exclusionary
diagnoses.
The types of specific exclusionary medical and psychiatric
conditions detected in clinic were similar for those other-
wise classified as CFS, ISF and NF (Table 4); thyroid dis-
ease, diabetes and anaemia were in the top four medical
exclusions for each group. Compared with the telephone
interview, a higher proportion of exclusionary diagnoses
identified in the clinic were psychiatric. However, the dis-
tribution of psychiatric diagnoses differed in that sub-
Table 1: Characteristics of clinically evaluated subjects
Characteristics Exclusionary Condition Odds ratio (OR)*
All Yes No Unadjusted Ors Adjusted Ors
n = 781 n = 280 (36%) n = 501 (64%) (95% CI)† (95% CI)
Part A
Classification
CFS-like 291 (37.26) 141 (48.45) 150 (51.55) 3.25 (2.03-4.80) 1.50 (0.79-2.87)
Unwell 267 (34.19) 89 (34.19) 178 (66.67) 1.73 (1.15-2.59) 0.89 (0.53-1.52)
Well 223 (28.55) 50 (22.42) 173 (77.58) 1.00 1.00
Age (years), mean (SD) 43.50 (10.36) 43.10 (10.39) 43.73 (10.35) 0.94 (0.81-1.09) 0.83 (0.70-1.00)
Sex
Male 186 (23.82) 71 (38.17) 115 (61.83) 1.14 (0.81-1.60) 1.44 (0.96-2.16)
Female 595 (76.18) 209 (35.13) 386 (64.87) 1.00 1.00
Race
Black 195 (24.97) 91 (46.67) 104 (53.33) 1.86 (1.34-2.60) 1.89 (1.24-2.88)
Other 35 (4.48) 13 (37.14) 22 (62.86) 1.26 (0.62-2.56) 1.12 (0.51-2.45)
White 551 (70.55) 176 (31.94) 375 (68.06) 1.00 1.00
Residential areas
Rural 383 (49.04) 144 (37.60) 239 (62.40) 1.81 (1.16-2.82) 2.02 (1.20-3.39)
Urban 266 (34.06) 103 (38.72) 163 (61.18) 1.90 (1.19-3.02) 1.96 (1.16-3.29)
Metropolitan 132 (16.90) 33 (25.00) 99 (75.00) 1.00 1.00
BMI (kg/m2), mean (SD) 28.08 (5.34) 28.76 (5.52) 27.70 (5.20) 1.22 (1.05-1.41) 1.02 (0.86-1.22)
Part B
MFI
Per SD increment Per SD increment
General fatigue 12.90 (4.69) 14.10 (4.36) 12.22 (4.74) 1.52 (1.30-1.78) 1.23 (0.87-1.74)
Physical fatigue 10.86 (4.37) 12.05 (4.32) 10.20 (4.25) 1.54 (1.32-1.79) 1.06 (0.78-1.44)
Reduced activity 9.24 (4.16) 10.13 (4.33) 8.75 (3.98) 1.39 (1.20-1.61) 0.93 (0.72-1.19)
Reduced motivation 9.58 (3.90) 10.60 (4.12) 9.01 (3.66) 1.51 (1.30-1.76) 1.21 (0.92-1.59)
Mental fatigue 10.94 (4.54) 12.09 (4.50) 10.29 (4.43) 1.50 (1.29-1.74) 1.12 (0.89-1.40)
SF-36 Per SD increment Per SD increment
Physical Functioning 75.64 (24.03) 67.57 (26.41) 80.11 (21.35) 1.68 (1.44-1.95) 0.62 (0.34-1.10)
Role physical 41.41 (41.60) 27.14 (37.45) 49.50 (41.68) 1.78 (1.52-2.09) 0.70 (0.50-0.99)
Bodily pain 60.61 (26.63) 52.35 (26.93) 65.23 (25.34) 1.65 (1.41-1.92) 0.66 (0.41-1.07)
Social functioning 71.32 (27.78) 62.28 (29.17) 76.37 (25.65) 1.67 (1.43-1.94) 1.08 (0.70-1.68)
Mental health 68.50 (22.23) 62.29 (23.05) 71.98 (20.99) 1.55 (1.33-1.80) 1.11 (0.63-1.94)
Role emotional 49.12 (43.31) 37.74 (41.49) 55.49 (43.05) 1.52 (1.31-1.77) 1.08 (0.78-1.50)
Vitality 47.77 (28.01) 41.39 (27.03) 51.38 (27.94) 1.44 (1.24-1.67) 1.61 (1.02-2.53)
General health 61.87 (23.57) 55.24 (23.88) 65.58 (22.58) 1.56 (1.34-1.82) 0.98 (0.64-1.52)
PCS 46.28 (10.72) 43.07 (11.64) 48.08 (9.72) 1.60 (1.38-1.86) 1.50 (0.40-5.68)
MCS 44.67 (12.79) 41.27 (13.63) 46.58 (11.89) 1.52 (1.31-1.76) 0.68 (0.22-2.07)
HUI2† 76.14 (14.61) 70.75 (14.80) 79.16 (13.61) 1.82 (1.56-2.13) Not included§
SI Per SD increment Per SD increment
SI_CFS 23.13 (20.58) 28.13 (21.45) 20.34 (19.56) 1.45 (1.25-1.68) 0.78 (0.56-1.08)
SI_NCFS 19.89 (18.09) 24.44 (20.21) 17.34 (16.26) 1.48 (1.27-1.71) 1.04 (0.79-1.37)
*Adjusted ORs were obtained for the multiple logistic regression models including all variables in the entire table; ORs with P-values < 0.05 are in 
bold font.
† Nichole's Health Utility Index 2 (HUI2) was included in the multivariate model because it is a linear combination of eight of the Medical Outcomes 
Survey Short Form-36 (SF-36) subscales and strongly correlated with physical component summary (PCS) and mental component summary (MCS).
CFS = chronic fatigue syndrome; CI = confidence interval; SD = standard deviation; BMI = body mass index; MFI = multidimensional fatigue 
inventory; SI_CFS = symptom inventory summary score of 8 CFS symptoms; SI_NCFS = symptom inventory summary score of non-CFS symptomsBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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stance abuse and psychosis accounted for all of the
exclusions in the NF group (57% and 7%, respectively)
and the ISF group but for only 34% collectively in the CSF
group where major depressive disorder with melancholic
features (MDD/M) was most common (48%). Twenty-
one percent of the 100 subjects who were classified as
'CFS, but for an exclusionary diagnosis', reported having
been previously diagnosed as CFS by a physician.
Characteristics of clinic population with medical versus 
psychiatric exclusions
Subjects with psychiatric exclusionary conditions were
significantly younger than subjects with medical exclu-
sions (mean age 39.9 years versus 45.4 years; P < 0.01;
Table 5). Subjects with psychiatric conditions also had sig-
nificantly higher mean scores (more fatigue) for the gen-
eral fatigue and mental fatigue subscales of the MFI and
non-CFS symptom inventory summary score. They also
had significantly lower scores (worse functioning or more
impaired) on several subscales of the SF-36 - particularly
mental health, role emotional and vitality, as well as the
health utility index - compared to subjects with medical
conditions (P < 0.01 for all; Table 5). However, the fatigue
lasted longer for those with medical exclusions than those
with psychiatric exclusions (mean 105 months versus 60
months, P < 0.01; Table 5).
Subjects with both medical and psychiatric diagnoses had
higher MFI-20 scores (more fatigue) in all dimensions
and these differences were statistically significant for phys-
ical fatigue, reduced activity and reduced motivation (P <
0.01 for all). In addition, subjects with both types of con-
ditions had significantly lower mean scores for SF-36 sub-
scales measuring physical functioning and role physical.
Subjects with only psychiatric exclusionary conditions
were significantly less impaired than those with only med-
ical exclusionary conditions for physical functioning and
in the physical component summary score (P < 0.01 for
both). Overall, the group with both types of exclusionary
diagnoses demonstrated greater fatigue, greater impair-
ment and higher symptom scores.
Risk factors for an exclusionary diagnosis in subjects 
otherwise CFS
Table 6 examines the factors associated with an exclusion-
ary diagnosis for the 210 subjects evaluated in the clinic
who fulfilled all other criteria for a diagnosis of CFS.
Unadjusted OR for BMI, higher scores (worse) in the
reduced motivation subscale of the MFI-20, lower scores
(worse) in the physical functioning, role physical, HU12
subscales of the SF-36 and the non-CFS symptom scores
of the symptom inventory all showed increased risks of
exclusion. However, after adjusting for all other variables
in the table, only the BMI remained significantly associ-
ated with having an exclusionary condition, with a 47%
increased risk for exclusion in subjects with a standard
deviation increment (5.13 kg/m2) of BMI (ORadj = 1.47,
95% confidence interval = 1.05, 2.06).
Discussion
The study illustrates the complexity that exclusionary con-
ditions introduce into both research and clinical consider-
ations of subjects potentially classified as CFS. The
exclusionary diagnoses are common; 28% of subjects in a
Table 2: Excluded participants by telephone interview classifications
Telephone interview
All Excluded (n = 1609)*
Medical (only) Psychiatric (only) Medical and psychiatric Missing data Subtotal (%)
n (%) n (%) n (%) n (%)
CFS-like 910 48% 350 79.4 60 13.6 31 7.0 0 0 441 27.4
Unwell 2635 37% 827 84.2 105 10.7 50 5.1 0 0 982 61.0
Well 2085 9% 164 88.2 16 8.6 6 3.2 0 0 186 11.6
Total 5630 29% 1341 83.3 181 11.3 87 5.4 0 0 1609 100
Clinic evaluation
CFS-like 291 49% 57 40.1 62 43.7 22 15.5 1 0.7 142 50.4
Unwell 267 43% 56 49.6 46 40.7 11 9.7 1 0.9 114 40.5
Well 223 12% 20 76.9 6 23.1 0 0.0 0 0.0 26 9.2
Total 783 36% 133 47.2 114 40.4 33 11.7 2 0.7 282 100
*Row percentages are listed unless other indicated
CFS = chronic fatigue symptomsBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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population-based sample had exclusions identified dur-
ing a personal history telephone interview. Exclusionary
conditions/diseases were subsequently recognized in an
additional 36% of subjects undergoing a full clinical
examination. It appears that during the telephone inter-
view subjects did not know of or did not remember all of
their exclusionary diagnoses. This discrepancy could be
due to: (1) greater accuracy and specificity of information
obtained by clinical examination compared to telephone
interview; (2) variable access to healthcare which, in turn,
means variable access to diagnostic means [16]; (3)
asymptomatic status contributing to unrecognized condi-
tions; or (4) a lack of perception of bodily feelings as
being abnormal. The types of diseases identified in the
clinic are recognized to be important in the differential
diagnosis of CFS and emphasize the need for clinicians to
evaluate patients with appropriate history taking, physical
examination and laboratory tests. The finding that Black
people and residents of rural and urban areas were more
likely to have exclusionary conditions diagnosed at a
clinic suggests that access to healthcare may be a contrib-
uting factor, as limited access to quality healthcare has
been documented among these subgroups [16]
The finding that increased BMI was independently associ-
ated with having an exclusionary condition among CFS
patients, suggests that the condition may be 'silent' as in
some correlates of elevated BMI, including metabolic con-
ditions, sleep disorders and hypothyroidism. This inter-
pretation is supported by the finding of exclusionary
conditions in 26 people who, in the telephone interview,
had considered themselves 'well'.
The diagnoses considered exclusionary for CFS were orig-
inally selected because they frequently result in symptoms
similar, if not identical, to those characteristic of CFS sub-
jects. As might be expected, differences between subjects
with and without exclusionary diagnoses were not univer-
Table 3: Numbers and types of exclusionary conditions
Telephone interview
(n = 5558*)
Clinic evaluation
(n = 781*)
n (%) n (%)
Medical
Morbid obesity
(BMI> = 40 kg/m2)
335 6.0 0 0
Pregnancy within the past year 282 5.1 0 0
HIV or AIDS 33 0.6 0 0
Organ transplantation 14 0.3 0 0
Sleep disorders 289 5.2 1 0.1
Neurological †105 1.9 4 0.5
Autoimmune/inflammatory ‡88 1.6 33 4.2
Cardiovascular 77 1.4 12 1.5
Infection §46 0.8 1 0.1
Cancer 28 0.5 0 0
Diabetes mellitus Type 1 22 0.4 22 2.8
Blood disorders 23 0.4 32 4.1
Lung disease 19 0.3 6 0.8
Liver 16 0.3 1 0.1
Renal 11 0.2 3 0.4
Surgery 10 0.2 0 0
Thyroid/pituitary 5 0.1 42 5.4
Other 72 1.3 9 1.2
Psychiatric
Bipolar 72 1.3 36 4.6
Substance abuse 49 0.9 63 8.1
Schizophrenia 30 0.5 16 2.0
MDD/M NE 41 5.2
Anorexia/bulimia 7 0.1 11 1.4
Other 7 0.1 0 0
Each condition identified in study participant was classified and listed separately; an individual may contribute more than one condition.
*Excludes subjects with missing or incomplete data
†Including strokes (45)
‡Including ulcerative colitis and Crohn's (34)
§ Including hepatitis C (37)
NE = not evaluated; BMI = body mass index; MDD/M = major depressive disorder with melancholic featuresBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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sally present. For example, general fatigue and reduced
activity scores of the MFI and physical function, role phys-
ical, social function and role emotional scores of the SF-
36 were equivalent. Likewise, CFS and non-CFS symptom
scores were not significantly different. Thus, in terms of
level of overall 'sickness' [17] and impairment, included
and excluded subjects were comparable. It is not surpris-
ing that subjects with both medical and psychiatric diag-
Table 4: Exclusionary medical and psychiatric conditions by clinical classification
CFS (n = 213) ISF (n = 421) NF (n = 147)
Medical conditions
Thyroid 23.81% Thyroid 26.76% Anaemia 25.00%
Diabetes 19.05% Anaemia 18.31% Thyroid 25.00%
Anaemia 9.52% Diabetes 16.90% Autoimmune 15.00%
Heart 9.52% Autoimmune 14.08% Diabetes 10.00%
Inflammatory 9.52% Inflammatory 4.23% Heart 5.00%
Arthritis 7.14% Heart 2.82% Hematologic 5.00%
Autoimmune 7.14% Kidney disease 2.82% Inflammatory 5.00%
Pulmonary 7.14% Metabolic 2.82% Kidney disease 5.00%
Kidney disease 2.38% Stroke 2.82% Metabolic 5.00%
Metabolic 2.38% Arthritis 1.41% Arthritis 0.00%
Sleep 2.38% Brain tumour 1.41% Brain tumour 0.00%
Brain tumour 0.00% Dehydration 1.41% Dehydration 0.00%
Dehydration 0.00% Pain syndrome 1.41% Liver disease 0.00%
Hematologic 0.00% Pulmonary 0.00% Pain syndrome 0.00%
Pain syndrome 0.00% Haematologic 0.00% Pulmonary 0.00%
Stroke 0.00% Liver disease 0.00% Sleep 0.00%
----------- ------------------ Sleep 0.00% Stroke 0.00%
Psychiatric conditions
MDD/M 47.73% Substance abuse 57.35% Psychosis 50.00%
Bipolar 27.27% Bipolar 26.47% Substance abuse 50.00%
Substance abuse 22.73% MDDM 14.71% MDDM 0.00%
Psychosis 11.36% Anorexia 10.29% Bipolar 0.00%
Anorexia 2.27% Psychosis 7.35% Anorexia 0.00%
CFS = chronic fatigue syndrome; ISF = insufficient fatigue; NF = non-fatigue; MDDM = major depressive disorder with melancholic features.BMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
Page 8 of 11
(page number not for citation purposes)
Table 5: Characteristics of subjects with exclusionary conditions by types of exclusions (n = 280)
Type of exclusion
Med (n = 133) Psych (n = 114) Both (n = 33) p-value
n% n % n%
Sex 0.0143
Female 109 81.95 75 65.79 25 75.76
Male 24 18.05 39 34.21 8 24.25
Race 0.6690
Black 48 46.09 33 28.95 10 30.30
White 78 58.65 77 67.54 21 63.64
Other 7 5.26 4 3.51 2 6.06
Residential areas 0.3099
Rural 60 45.11 65 57.02 19 57.58
Urban 57 42.86 35 30.70 11 33.33
Metropolitan 16 12.03 14 12.28 3 9.09
Mean SD Mean SD Mean SD
Duration of fatigue (months) *† 105.45 96.73 59.92 59.58 120.17 92.96 0.0003
BMI 29.27 5.68 27.94 5.38 29.55 5.10 0.115
MFI
General
fatigue †‡
13.10 4.55 14.69 4.18 16.15 2.99 <0.001
Physical
fatigue *‡
11.68 4.49 11.74 4.09 14.58 3.68 0.002
Reduced
activity ‡
9.54 4.19 10.11 4.41 12.55 3.88 0.002
Reduced
motivation ‡
9.95 3.86 10.71 4.33 12.88 3.57 0.001
Mental
fatigue†‡
10.83 4.39 13.05 4.32 13.85 4.24 <0.001
SF-36
Physical
functioning*
67.86 27.04 71.36 24.82 53.33 25.15 0.002
Role physical ‡ 31.20 40.17 27.41 36.28 9.85 23.33 0.013
Bodily pain 54.08 26.85 53.23 26.29 42.18 28.05 0.067
Social
functioning ‡
68.80 26.72 58.44 30.87 49.24 26.51 <0.001
Mental
health†‡
71.43 18.78 56.18 24.07 46.55 19.84 <0.001
Role
emotional†‡
48.87 43.53 31.58 39.13 14.13 23.61 <0.001
Vitality*†‡ 48.83 26.81 38.03 26.50 23.03 17.59 <0.001
General
health*‡
57.67 24.09 56.48 22.33 41.18 24.19 0.001
PCS* § 42.22 11.64 45.43 11.32 38.31 11.16 0.0040
MCS†‡§ 46.55 11.24 37.36 14.72 33.47 10.02 <0.0001
HUI2*‡§ 74.50 14.32 69.34 14.72 60.50 11.25 <0.0001
Symptom scores
CFS symptom
summary score ‡
23.98 20.70 30.13 21.14 37.98 21.90 0.0014
Non-CFS
symptom
summary score†‡
18.71 17.93 27.86 30.38 35.67 21.40 <0.0001
* Indicates the p-value for an post-hoc comparison between both and medical types with Tukey p-adjustment less than 0.01 for multiple group 
comparison.
† Indicates the P-value for a post hoc comparison between medcial and psychiatric types with Tukey P-adjustment less than 0.01 for multiple group 
comparison.
‡ Indicates the P-value for a post hoc comparison between both and psychiatric types with Tukey P-adjustment less than 0.01 for multiple group 
comparison.
§ Nichol's health utility index 2 (HUI2) [14] was included in the multivariate model because it is a linear combination of 8 SF-36 subscales and 
strongly correlated with Physical Component Summary (PCS) and Mental Component Summary (MCS).BMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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noses have more fatigue and impairment, as well as higher
symptom scores, than those with only medical or psychi-
atric conditions. However, greater impairment in selected
parameters in those subjects with only psychiatric exclu-
sions versus those with only medical exclusions reflects a
true difference or bias introduced by the self-report proce-
dure.
Although not emphasizing the differences between sub-
jects who fulfill defined requirements for exclusionary
diagnoses and those who do not, previous studies of
chronic fatigue and CFS have shown high rates of psychi-
atric morbidity and functional morbidity and have docu-
mented these outcomes as important public health
burdens [18,19]. Another study, which included 98 sub-
jects with chronic fatigue and compared disability and
psychosocial distress in those that met criteria for CFS and
those who had medical or psychiatric exclusions, failed to
meet the definition or were using medications specific to
the study [20]. The study results showed that the CFS sub-
jects could not be differentiated from those who were
excluded based on the study variables that addressed
Table 6: Factors associated with the presence of exclusionary condition among subjects classified as chronic fatigue syndrome (CFS) at 
clinic evaluation
Characteristics Exclusionary condition Odds ratio (OR)
All Yes No Unadjusted ORs Adjusted ORs
n = 210 n = 100 (48%) n = 110 (52%) (95% CI)† (95% CI)
Telephone Classification
CFS-like 169 80.48 85 50.30 84 49.70 1.75 (0.87-3.54) 1.48 (0.61-3.56)
Unwell 41 19.52 15 36.59 26 63.41 1.00 1.00
Age (years), mean (standard deviation, SD) 45.06 (9.65) 45.99 (8.98) 44.22 (10.19) 1.21 (0.92-1.59) 1.06 (0.74-1.54)
Sex
Male 38 18.10 18 47.37 20 52.63 0.99 (0.49-2.00) 1.65 (0.69-3.92)
Female 172 81.90 82 47.67 90 52.33 1.00 1.00
Race
Black 35 16.67 14 40.00 21 60.00 0.67 (0.32-1.40) 0.56 (0.20-1.52)
Other 13 6.19 5 38.46 8 61.54 0.63 (0.20-1.99) 0.62 (0.15-2.51)
White 162 77.14 81 50.00 81 50.00 1.00 1.00
Residential areas
Rural 106 50.48 54 50.94 52 49.06 2.28 (0.99-5.29) 1.47 (0.51-4.20)
Urban 72 34.29 36 50.00 36 50.00 2.20 (0.91-5.30) 1.53 (0.55-4.27)
Metropolitan 32 15.24 10 31.25 22 68.75 1.00 1.00
Body mass index (kg/m2), mean (SD) 28.69 (5.18) 29.50 (5.42) 27.95 (4.87) 1.36 (1.03-1.79) 1.47 (1.05-2.06)
Multidimensional fatigue inventory Per SD increment Per SD increment
General fatigue 17.05 (2.36) 17.34 (2.09) 16.79 (2.57) 1.27 (0.96-1.70) 1.22 (0.81-1.84)
Physical fatigue 14.52 (3.31) 14.88 (3.22) 14.19 (3.38) 1.24 (0.94-1.63) 0.83 (0.52-1.34)
Reduced Activity 11.96 (4.10) 12.33 (4.19) 11.63 (4.02) 1.19 (0.90-1.56) 0.83 (0.54-1.26)
Reduced Motivation 12.44 (3.38) 13.05 (3.63) 11.89 (3.05) 1.43 (1.07-1.89) 1.44 (0.94-2.20)
Mental fatigue 14.05 (3.75) 14.49 (3.72) 13.65 (3.75) 1.25 (0.95-1.65) 1.19 (0.80-1.77)
SF-36 Per SD increment Per SD increment
Physical functioning 57.37 (24.54) 52.83 (24.01) 61.45 (24.40) 0.70 (0.53-0.92) 0.77 (0.28-2.12)
Role physical 9.05 (19.45) 5.50 (13.09) 12.27 (23.40) 0.67 (0.48-0.93) 0.63 (0.40-1.00)
Bodily pain 38.30 (19.86) 35.66 (18.93) 40.70 (20.46) 0.77 (0.58-1.02) 0.60 (0.27-1.31)
Social functioning 49.82 (24.74) 47.25 (26.03) 52.16 (23.39) 0.82 (0.62-1.08) 1.24 (0.62-2.46)
Mental health 54.27 (22.15) 52.04 (21.59) 56.29 (22.55) 0.82 (0.63-1.08) 1.38 (0.55-3.46)
Role emotional 27.46 (37.36) 23.66 (35.23) 30.90 (39.03) 0.82 (0.62-1.08) 0.94 (0.55-1.61)
Vitality 22.29 (16.21) 21.55 (16.96) 22.95 (15.54) 0.92 (0.70-1.20) 1.20 (0.72-1.99)
General health 40.17 (19.46) 38.10 (20.87) 42.05 (17.97) 0.81 (0.62-1.07) 0.99 (0.51-1.92)
PCS* 36.67 (9.92) 35.31 (9.91) 37.91 (9.81) 0.77 (0.58-1.01) 1.47 (0.17-12.75)
MCS* 36.75 (12.58) 35.75 (12.78) 37.67 (12.39) 0.86 (0.65-1.13) 0.69 (0.12-3.99)
HUI2* 61.94 (10.80) 59.95 (10.96) 63.76 (10.37) 0.69 (0.52-0.92) Not included
SI Per SD increment Per SD increment
SI_CFS 49.03 (16.60) 50.20 (15.94) 47.97 (17.17) 1.15 (0.87-1.50) 0.68 (0.42-1.11)
SI_NCFS 36.98 (18.68) 39.95 (19.63) 34.24 (17.40) 1.37 (1.03-1.82) 1.47 (0.93-2.32)
Note: adjusted ORs were obtained for the multiple logistic regression models including all variables in the table; p-value < 0.05 were in bold font.
* Nichole's health utility index 2 (HUI2) was included in the multivariate model because it is a linear combination of 8 SF-36 subscales and strongly 
correlated with Physical Component Summary (PCS) and Mental Component Summary (MCS).
CI: confidence interval; SI_CFS: symptom inventory summary score of 8 CFS symptoms; SI_NCFS: symptom inventory summary score of non-CFS 
symptomsBMC Medicine 2009, 7:57 http://www.biomedcentral.com/1741-7015/7/57
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symptoms of depression, general health, impairment,
symptom perception and somatic and psychological
stress.
In principle, the results of this study, and of previous
observations, support the original decision to exclude
subjects with fatigue and selected concurrent identifiable
illnesses/diseases from the research diagnosis of CFS as
the latter shares illness characteristics and consequences
with the syndrome [1]. The excluded group may have
exposures or disease components that would confound
efforts to address the incidence, prevalence or pathophys-
iology of an otherwise unexplained condition such as CFS
if it were unique [21,22]. We did not address the question
of subject competency to complete the in the psychiatric
exclusions. Thus, considering CFS as a diagnostic possibil-
ity and pursuing a differential diagnostic process should
allow identification of patients who need careful evalua-
tions as is recommended in the 1994 definition. In partic-
ular, obesity, anaemia, thyroid disease, diabetes and heart
disease are common in fatigued as well as non-fatigued
subjects (Table 3 and 4).
It is equally clear that subjects with exclusionary diag-
noses are at least as comparably functionally impaired as
the included subjects. The chronically unwell population,
identified here with a fatiguing illness, is likely to have a
medical disease and/or a psychiatric disease. However,
these conditions may go undiagnosed. Since subjects with
and without identifiable exclusionary disease processes
share many symptoms, clinical management requires
careful attention in order to correctly identify and treat the
medical and psychiatric illnesses. It is clear that treatment
of the underlying diseases will not resolve fatigue and
symptoms in all instances and it is possible that illnesses/
diseases with chronic fatigue share a common underlying
pathophysiologic mechanism. In order to examine this
possibility, subjects with exclusionary conditions could
be included with CSF cases for comparison.
The primary limitation of this study is the inclusion of
subjects who have been ill for an average of 6-7 years. The
majority of the subjects had experienced a gradual onset
of their illness. Thus the exclusion of subjects fulfilling
CFS criteria and having medical and/or psychiatric ill-
nesses may be observed more frequently in the popula-
tion under study than in the younger individuals with an
acute onset. Likewise, the levels of impairment may also
be more applicable to this population. Replication of
these observations will be possible in future follow-up
studies.
As those with CFS suffer from personal, social, workplace
[1] and observed financial losses [23], should not all indi-
viduals fulfilling CFS inclusion criteria, with or without
exclusionary diagnoses, be considered in future public
health planning? For instance, would both groups benefit
from prevention and intervention efforts such as cognitive
behavioral therapy and graded exercise therapy [24,25]? A
similar question could be asked of those who are unwell
but who do not reach the diagnostic threshold.
Conclusion
This analysis allows three different, but complementary,
interpretations of the results that need to be addressed in
future studies. First, it substantiates the need for the iden-
tification of underlying diagnoses that impact the choice
of subjects for epidemiological and mechanistic studies of
a specifically described illness construct. Secondly, it sug-
gests that those who would otherwise fulfill the CFS defi-
nition, but who have an exclusionary illness or disease,
are as impaired as those defined as having CFS. The third
interpretation is that CFS, in the population studied here,
may reflect underlying medical or psychiatric illnesses or
diseases that are not necessarily 'under control'. The data
therefore suggest that, in order to substantiate CFS as a
specific entity or to identify shared pathophysiological
factors, subjects fulfilling the criteria of fatiguing illnesses,
but who have exclusionary and non-exclusionary diag-
noses, need to be included as comparison case groups in
both mechanistic and therapeutic studies. The identifica-
tion of subjects for CFS studies requires a clinical evalua-
tion; medical and psychiatric histories obtained by
telephone interviews are not completely reliable.
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